APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells

Chemoresistance is one of the leading causes of cancer-related deaths in the United States. Triple negative breast cancer (TNBC), a subtype lacking the known breast cancer receptors used for targeted therapy, is reliant on chemotherapy as the standard of care. The Adenomatous Polyposis Coli (APC) tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanski, Casey D., Keffler, Kaitlyn, McClintock, Stephanie, Milac, Lauren, Prosperi, Jenifer R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872841/
https://www.ncbi.nlm.nih.gov/pubmed/31759252
http://dx.doi.org/10.1016/j.neo.2019.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872841/
https://www.ncbi.nlm.nih.gov/pubmed/31759252
http://dx.doi.org/10.1016/j.neo.2019.09.002

Ejemplares similares